“These are exciting times for us at Southern Sun Pathology. We have always been proud to push ourselves towards the forefront of technology. We have recently taken huge steps in the areas of digital pathology and the treatment of skin cancer. Our partnership with Sectra will play an important role in realizing substantial benefits for our pathologists and the care we provide today and supports our ambitions within artificial intelligence,” says Dr Ian Katz, founder of Southern Sun Pathology and a pathologist specializing in skin cancer.
Sectra’s pathology solution is part of its enterprise imaging offering. It provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise.
About Sectra
Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange.
Back to HCB News
